ConvaTec Group PLC (LON:CTEC) Insider Karim Bitar Sells 132,253 Shares

ConvaTec Group PLC (LON:CTEC - Get Free Report) insider Karim Bitar sold 132,253 shares of the firm's stock in a transaction on Friday, March 14th. The stock was sold at an average price of GBX 256 ($3.31), for a total value of £338,567.68 ($437,143.55).

Karim Bitar also recently made the following trade(s):

• On Monday, March 17th, Karim Bitar sold 436,692 shares of ConvaTec Group stock. The stock was sold at an average price of GBX 256 ($3.31), for a total value of £1,117,931.52 ($1,443,423.52).

ConvaTec Group Price Performance

LON:CTEC traded down GBX 2 ($0.03) during trading hours on Friday, hitting GBX 257 ($3.32). 11,241,307 shares of the company's stock traded hands, compared to its average volume of 20,111,834. The firm has a market cap of £6.54 billion, a P/E ratio of 43.28, a P/E/G ratio of 0.93 and a beta of 0.64. ConvaTec Group PLC has a 52 week low of GBX 211.80 ($2.73) and a 52 week high of GBX 295.20 ($3.81). The business's fifty day simple moving average is GBX 248.35 and its two-hundred day simple moving average is GBX 234.96. The company has a quick ratio of 0.96, a current ratio of 2.26 and a debt-to-equity ratio of 85.32.

ConvaTec Group Increases Dividend

The firm also recently disclosed a dividend, which will be paid on Thursday, May 29th. Investors of record on Thursday, April 17th will be paid a dividend of $0.05 per share. This is a positive change from ConvaTec Group's previous dividend of $0.02. The ex-dividend date of this dividend is Thursday, April 17th. This represents a yield of 1.36%. ConvaTec Group's dividend payout ratio (DPR) is currently 84.20%.

Remove Ads

Analyst Ratings Changes

Separately, Berenberg Bank reaffirmed a "buy" rating and issued a GBX 310 ($4.00) price target on shares of ConvaTec Group in a report on Wednesday, March 5th.

ConvaTec Group Company Profile

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns.